Baselga Cancer Research Scholar

At AstraZeneca, we pride ourselves on crafting a collaborative culture that champions knowledge-sharing, ambitious thinking and innovation – ultimately providing employees with the opportunity to work across teams, functions and even the globe.

Recognizing the importance of individualized flexibility, our ways of working allow employees to balance personal and work commitments while ensuring we continue to create a strong culture of collaboration and teamwork by engaging face-to-face in our offices 3 days a week. Our head office and Blue Sky Hub in downtown Toronto are purposely designed with collaboration in mind, providing space where teams can come together to strategize, brainstorm and connect on key projects.

Our dedication to sustainability is also central to our culture and part of what makes AstraZeneca a great place to work. We know the health of people, the planet and our business are interconnected which is why we’re taking ambitious action to tackle some of the biggest challenges of our time, from climate change to access to healthcare and disease prevention.

The Baselga Cancer Research Scholars Program, initiated in 2020, is a 2-year immersive education and research program for early-career Oncologists who are inspired by science and by how clinical development has the potential to transform patient care. As part of a competitively selected cohort of Scholars, you will join an accelerated development track within Oncology R&D. With individualized mentorship, there is opportunity to learn from a diverse group of experts across the drug development continuum, playing a pivotal role in channelling our scientific capabilities to make a positive impact on changing patients’ lives.

Selected Scholars will join the current cohort of Baselga Cancer Research Scholars, building a vibrant community of drug developers. We are currently recruiting for the 2027 class with an aim to start the position in summer-autumn 2027.

Our Oncology strategy is built with one goal in mind – pushing the boundaries of science to deliver life-changing medicines to patients. We have a passion for discovery and a broad pipeline of next-generation medicines, and together with a focus on execution excellence, we aim to expand treatment options and improve outcomes for patients with solid and haematological cancers. We’re pioneering innovative research across six scientific platforms:
Tumor drivers and resistance;
Immuno-oncology, DNA damage response, Antibody drug conjugates, Epigenetics and Cell therapies.

Our ambition is to eliminate cancer as a cause of death. It’s our big vision that unites and inspires us. With multiple indications and high-quality molecules at all stages of our innovative pipeline, we keep pushing forward. Focusing on cutting-edge science with the latest technology to achieve breakthroughs. AZ is a place built on courage, curiosity and collaboration – we make bold decisions driven by patient outcomes.

The 2027 AZ Baselga Cancer Research Scholars cohort will join AstraZeneca at a time of tremendous growth and acceleration in the oncology biologics portfolio. Working in a fast-paced and dynamic work environment you will experience increasing levels of responsibility, following a structured learning plan in the following domains:

1)
Clinical Study Assignment: You will join a clinical study team and build experience as a medical leader in clinical development which could be in Early Clinical Development, Late Clinical Development, or one…